Insulet Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome, everyone. I'm Robbie Marcus, med-tech analyst at JPMorgan. I'm very happy to have Insulet for our next presentation. We're going to have CEO, Shacey Petrovic, lead the presentation and Q&A.
Just some housekeeping reminders. Go ahead to the health care website, and you can follow along with the slide deck to Shacey's remarks. Also, you can e-mail a question to me, and I can ask it in Q&A,or submit a question on the conference website, and I'll do my best to ask in Q&A.
So with that, Shacey, take it away.
Great. Thanks, Robbie. It's great to be here with you and to have the opportunity to share Insulet's great growth story with everyone. If we could open up the presentation? Great.
So Insulet, for those of you that are not familiar, is a company centered on a simple but powerful mission to improve the lives of people living with diabetes. We are the manufacturer of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |